$30 Billion Deal, page-67

Thanks for that posting kpt.

I am a little confused now.
The interviewer references a 2007 patent and Michelle then goes onto talk about HIV however their website only lists the 2007 patent as HCV. She also talks about a later patent which is not on the website.
Future compound patents will be fantastic when relevant however at the moment and for the last number of year Biotron’s focus has been bit225 which I expect would be the commercial avenue.

I guess I will just cross my fingers that they know what they’re doing, not the ideal way to invest however I don’t currently have much invested so not a huge worry for me.